ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 79 filers reported holding ALLOVIR INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,008 | +67.3% | 48,376 | +206.7% | 0.00% | – |
| Q1 2023 | $62,150 | -47.0% | 15,774 | -31.0% | 0.00% | – |
| Q4 2022 | $117,262 | -45.5% | 22,858 | -16.0% | 0.00% | – |
| Q3 2022 | $215,000 | +77.7% | 27,213 | -12.3% | 0.00% | – |
| Q2 2022 | $121,000 | +75.4% | 31,046 | +202.6% | 0.00% | – |
| Q1 2022 | $69,000 | -81.6% | 10,260 | -46.0% | 0.00% | – |
| Q2 2021 | $375,000 | +20.6% | 18,986 | +67.6% | 0.00% | – |
| Q3 2020 | $311,000 | – | 11,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |